ZyVersa Therapeutics Inc. and Larkspur Health Acquisition Corp. Close Business Combination; ZyVersa Expected to Begin Trading on Nasdaq December 13, 2022 (Ticker “ZVSA”)
ZyVersa is a scientific stage biopharmaceutical firm growing first-in-class product candidates for therapy of renal and ...
Read more